Universal Biosensors Inc 's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Universal Biosensors Inc 's ROA in the second quarter of 2025?
Universal Biosensors Inc recorded a cumulative net loss of $-17 million during 12 months ending in the second quarter of 2025, resulting in a negative return on assets (ROA) of -63.27%.

However, within the Healthcare sector 694 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2025 from 4275 to 4284.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Total Assets Change	-50.13 %	-40.75 %	-39.61 %	-11.49 %	34.56 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-17	-15	-14	-12	-11
Return On Assets (TTM)	-63.27 %	-43.83 %	-37.66 %	-27.61 %	-25.09 %
UBI's Total Ranking	# 4284	# 4275	# 4921	#	#
Total Assets (TTM) in million	23	26	29	32	46
Seq. Total Assets Change	-9.96 %	-12.13 %	-9.51 %	-30.35 %	6.99 %
Seq. Net Income Change	-	-	-	-	-

UBI's 5 Years Annual ROA >> Back to UBI Management Effectiveness >> Compare UBI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 158
Sector	# 695
Overall	# 4229

Return On Assets Statistics
High	Average	Low
-2.4 %	-50.77 %	-72.83 %
(Sep 30 2021)		(Jun 30 2025)

Financial Statements
Universal Biosensors Inc 's Assets	$ 23 million	UBI's Balance sheet
Universal Biosensors Inc 's Income	$ -7 million	Quarterly UBI's Income Statement
UBI's Income by Division		See UBI's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020
Y / Y Total Assets Change	-9.48 %	-18.06 %	6.2 %	-15.19 %	-
Total Assets in million	46	51	62	59	69
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-14	0	-27	-11	-8
Annual Return On Assets	-30.86 %	0 %	-43.16 %	-17.94 %	-11.06 %

UBI's 5 Years Annual ROA >> Back to UBI Management Effectiveness >> Compare UBI ROA to its Competitors

More Return On Assets Ratios
UBI's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
UBI's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for UBI's Competitors
Subscribers only: Roa for Universal Biosensors Inc 's Suppliers
Subscribers only: Return On Assets for UBI's Customers

You may also want to know
UBI's Roi	UBI's Inventory Turnover Ratio	UBI's Growth Rates	UBI's Dividend Comparisons
	UBI's Profitability Ratios	UBI's Asset Turnover Ratio	UBI's Dividend Growth
UBI's Roe	UBI's Valuation Ratios	UBI's Financial Strength Ratios	UBI's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector

ROA

Date modified: 2026-09-26T06:59:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.